IR Contact

Catherine Sulawske-Guck

Investor Relations

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Bioheart, Inc.'s financial performance into perspective.

Latest SEC Filings

BIOHEART, INC. Files SEC form 10Q, November 14, 2011 Interactive Data

BIOHEART, INC. Files SEC form 8K, September 6, 2011

BIOHEART, INC. Files SEC form 14C, August 16, 2011

BIOHEART, INC. Files SEC form 10Q, August 15, 2011 Interactive Data

BIOHEART, INC. Files SEC form S8, August 3, 2011

BIOHEART, INC. Files SEC form 8-K, June 15, 2011

BIOHEART, INC. Files SEC form 8-K, May 25, 2011

10-Q Quarterly Report, May 23, 2011

BIOHEART, INC. Files SEC form 10-K, May 10, 2011

BIOHEART, INC. Files SEC form 8-K, April 18, 2011

BIOHEART, INC. Files SEC form 8-K, March 11, 2011

BIOHEART, INC. Files SEC form 8-K, Changes in Registrants Certifying Accountant, February 23, 2011

BIOHEART, INC. Files SEC form 8-K, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers, February 9, 2011

BIOHEART, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities, January 12, 2011

Archived SEC Filings

BIOHEART, INC. Files SEC form 8-K, Regulation FD Disclosure, December 16, 2010

BIOHEART, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities, December 13, 2010

BIOHEART, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities, November 30, 2010

10-Q Quarterly Report, November 15, 2010

BIOHEART, INC. Files SEC form 8-K, Other Events, October 26, 2010

BIOHEART, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, October 25, 2010

BIOHEART, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, October 6, 2010

BIOHEART, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities; Regulation FD Disclosure, September 20, 2010

BIOHEART, INC. Files SEC form 8-K, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers, Sept 6, 2010

10-Q Quarterly Report, August 20, 2010

BIOHEART, INC. Files SEC form 8-K, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers, Aug 13, 2010

BIOHEART, INC. Files SEC form 8-K, Unregistered Sales of Equity Securities and Regulation FD disclosures, July 20, 2010

BIOHEART, INC. Files SEC form 8-K, Triggering Events That Accelerate or Increase a Direct Financial Obligation, Other Events, July 16, 2010

BIOHEART, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, July 1, 2010

BIOHEART, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, June 19, 2010

Form 10-Q for BIOHEART, INC., May 19, 2010

BIOHEART INC Files Form 10-K, March 31, 2010

BIOHEART, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, February 17, 2010

BIOHEART, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, February 5, 2010

BIOHEART, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, January 6, 2010

BIOHEART, INC. Files SEC form 8-K, Regulation FD Disclosure, December 14, 2009

8-K Current Report, December 1, 2009

BIOHEART, INC. Financials, November 19, 2009

Form 10-Q for BIOHEART, INC., Novenmber 13, 2009

BIOHEART, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits, November 12, 2009

10-Q Quarterly Report, August 18, 2009

8-K Current Report, August 18, 2009

Corporate Governance

The Board of Directors of Bioheart, Inc. (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.

Code of Business Conduct and Ethics

Code of Ethics for Chief Executive Officer and Senior Financial Officers

Audit Committee Charter

Compensation Committee Charter

Governance and Nominating Committee Charter